Newly developed addiction-free pain reliever targets inflammation

Researchers with the University of Virginia have detailed the discovery of a potential new pain reliever that shows promise for offering relief without the addiction potential of existing opioid pain medication. According to a newly published study, the pain relief involves diacylglycerol lipase-beta (DAGL?) inhibitors that show anti-inflammation and pain relieving potential without the negative side effects. Pain relievers, though …